{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:43:43Z","timestamp":1789559023094,"version":"build-2803163510"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T00:00:00Z","timestamp":1436140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131158","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T18:53:09Z","timestamp":1436208789000},"page":"e0131158","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Radiotherapy Compared to Other Strategies in the Treatment of Stage I\/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years"],"prefix":"10.1371","volume":"10","author":[{"given":"Dlawer Abdulla","family":"Barzenje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milada","family":"Cvancarova Sm\u00e5stuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Liest\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Delabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Holte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin&apos;s lymphoma. The Non-Hodgkin&apos;s Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/bjc.1994.213","article-title":"Clinical stage 1 non-Hodgkin&apos;s lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy","volume":"69","author":"Hudson B Vaughan","year":"1994","journal-title":"British journal of cancer"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0167-8140(88)90030-8","article-title":"Localized follicular lymphomas: prognosis and survival of stages I and II in a retrospective series of 103 patients","volume":"13","author":"P Soubeyran","year":"1988","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","article-title":"Long-term outcome and mortality trends in early-stage, Grade 1\u20132 follicular lymphoma treated with radiation therapy","volume":"64","author":"BA Guadagnolo","year":"2006","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.2003.07.111","article-title":"Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin&apos;s lymphoma","volume":"21","author":"JF Seymour","year":"2003","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","article-title":"Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University","volume":"14","author":"MP Mac Manus","year":"1996","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02990087","article-title":"A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-","volume":"11","author":"SM Kelsey","year":"1994","journal-title":"Hodgkins lymphoma. Medical oncology"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1002\/cncr.25117","article-title":"Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy","volume":"116","author":"BA Campbell","year":"2010","journal-title":"Cancer"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I","article-title":"Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study","volume":"71","author":"J Yahalom","year":"1993","journal-title":"Cancer"},{"issue":"8580","key":"ref10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"AG Stansfeld","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"NL Harris","year":"1994","journal-title":"Blood"},{"key":"ref12","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH CE Swerdlow","year":"2008"},{"issue":"11","key":"ref13","first-page":"1860","article-title":"Report of the Committee on Hodgkin&apos;s Disease Staging Classification","volume":"31","author":"PP Carbone","year":"1971","journal-title":"Cancer research"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin&apos;s disease: Cotswolds meeting","volume":"7","author":"TA Lister","year":"1989","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"9","key":"ref15","first-page":"1598","article-title":"Cotswolds modification of the Ann Arbor staging system for Hodgkin&apos;s disease","volume":"8","author":"CL Olweny","year":"1990","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"P Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"MM Oken","year":"1982","journal-title":"American journal of clinical oncology"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin&apos;s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"BD Cheson","year":"1999","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"ref19","first-page":"1219","article-title":"Long-term results with radiotherapy for Stage I-II follicular lymphomas. International journal of radiation oncology, biology","volume":"51","author":"RB Wilder","year":"2001","journal-title":"physics"},{"issue":"27","key":"ref20","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1200\/JCO.2011.40.6546","article-title":"Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study","volume":"30","author":"JW Friedberg","year":"2012","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/oxfordjournals.annonc.a010720","article-title":"Is there any place for a wait-and-see policy in stage I0 follicular lymphoma?: A study of 43 consecutive patients in a single center","volume":"7","author":"P Soubeyran","year":"1996","journal-title":"Annals of Oncology"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1200\/JCO.2004.10.086","article-title":"Stage I and II follicular non-Hodgkin&apos;s lymphoma: long-term follow-up of no initial therapy","volume":"22","author":"R Advani","year":"2004","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1986.4.10.1470","article-title":"Follicular lymphoma: prognostic factors for response and survival","volume":"4","author":"CJ Gallagher","year":"1986","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000421-198602000-00011","article-title":"Treatment of early\u2014stages I and II\u2014nodular, poorly differentiated lymphocytic lymphoma","volume":"9","author":"GA Gomez","year":"1986","journal-title":"American journal of clinical oncology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"L Lowry","year":"2011","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"29","key":"ref26","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1200\/JCO.2010.28.4786","article-title":"Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35\/98","volume":"28","author":"G Martinelli","year":"2010","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2014. Epub 2014\/08\/13. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1200\/jco.2013.54.8800\" xlink:type=\"simple\">10.1200\/jco.2013.54.8800<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">25113753<\/object-id>.","DOI":"10.1200\/JCO.2013.54.8800"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood-2003-04-1124","article-title":"Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients","volume":"103","author":"M Andre","year":"2004","journal-title":"Blood"},{"issue":"446","key":"ref29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"PF Jason","year":"1999","journal-title":"Journal of the American Statistical Association"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"H Putter","year":"2007","journal-title":"Statistics in medicine"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"PK Andersen","year":"2012","journal-title":"Int J Epidemiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T18:03:35Z","timestamp":1599242615000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131158"}},"subtitle":[],"editor":[{"given":"Masaru","family":"Katoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131158","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,6]]}}}